Subscribe to the newsletter

Publication — IRIC

Dimerization-induced allostery in protein kinase regulation.

The ability of protein kinases to switch between inactive and active states is critical to control the outputs of cellular signaling pathways. In several protein kinases, the conformation of helix αC is a key hub on which regulatory inputs converge to induce catalytic switching. An emerging mechanism involved in regulating helix αC orientation is the allosteric coupling with kinase domain surfaces involved in homo- or heterodimerization. In this review, we discuss dimerization-mediated regulation of the rapidly accelerated fibrosarcoma (RAF) and eIF2α kinase families and draw parallels with the analogous behavior of the epidermal growth factor receptor (EGFR) and serine/threonine-protein kinase endoribonuclease 1 (IRE1)/ribonuclease L (RNAse L) kinase families. Given that resistance to RAF-targeted therapeutics often stems from dimerization-dependent mechanisms, we suggest that a better understanding of dimerization-induced allostery may assist in developing alternate therapeutic strategies.

Publication date
October 1, 2014
Principal Investigators
Lavoie H, Li JJ, Thevakumaran N, Therrien M, Sicheri F
PubMed reference
Trends Biochem. Sci. 2014;39(10):475-486
PubMed ID
25220378
Affiliation
Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, H3C 3J7, Canada.